Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 27Terminated 9Unknown 6Recruiting 3Not yet recruiting 3Active not recruiting 3Withdrawn 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Head & Neck 1

Conditions

Small Cell Lung Carcinoma 14Recurrence 3Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Unresectable Locally Advanced or Metastatic Solid Tumors 1Squamous Cell Carcinoma of Head and Neck 1SCLC, Extensive Stage 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Medulloblastoma 1Lung 1Leukemia 1Head and Neck Neoplasms 1Extrapulmonary Neuroendocrine Cancer 1Extensive Stage Lung Small Cell Cancer 1Extensive Small Cell Lung Cancer 1Ependymoma 1ES-SCLC 1Carcinoma, Squamous Cell 1Carcinoma, Pancreatic Ductal 1Carcinoma, Merkel Cell 1Carcinoma 1

Interventions

Cyclophosphamide 6fludarabine 5toripalimab 3Paclitaxel 3Etoposide 3Carboplatin 3Bevacizumab 3zimberelimab 2tislelizumab 2sintilimab 2glumetinib 2Vincristine 2Temozolomide 2Platinum 2Immune Checkpoint Inhibitors 2Hepatectomy 2Gemcitabine 2Drug Therapy 2Docetaxel 2Cisplatin 2Capecitabine 2venetoclax 1relmacabtagene autoleucel 1osimertinib 1lenvatinib 1irinotecan sucrosofate 1glofitamab 1gallium maltolate 1fludarabine phosphate 1eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Recurrence × Etoposide × Clear all
NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

National Cancer Institute, Egypt

Phase 2 Not yet recruiting
120 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07097948 2025-08-01

Adjuvant

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Not yet recruiting
40 enrolled
Thoracic

Recurrence, Small Cell Lung Carcinoma

NCT06648200 2024-10-18

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Not yet recruiting
100 enrolled
Thoracic

Recurrence, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡